Idiopathic Pulmonary Arterial Hypertension Newly Diagnosed in Pregnancy with Anemia and Threatened Preterm Labor

Stefani Harumsari, Bambang Rahardjo, Nugrahanti Prasetyorini, Pande Made Dwijayasa, Valerinna Yogibuana, Mohammad Saifur Rohman


Background: Pulmonary hypertension (PH) is a rare cardiovascular disorder that leads to right heart failure (RHF). Although most PH occurs secondary to congenital heart disease (CHD), PH can occur primarily due to pulmonary arterial vasculature abnormalities, known as Idiopathic pulmonary arterial hypertension (IPAH). In addition, the physiologic changes during pregnancy can potentially lead to worsening PAH and confer a poor prognosis. Therefore, when the mother refuses termination, a multidisciplinary team should manage the pregnancy and delivery to improve maternal and fetal outcomes.

Objectives: This case report aimed to describe the importance of early diagnosis and treatment in PAH.

Case reports: We reported a case of a 24-year-old woman with idiopathic pulmonary arterial hypertension (IPAH) that was newly diagnosed at 25 weeks of pregnancy and previously misdiagnosed with patent ductus arteriosus (PDA). This pregnancy was complicated with anemia and threatened preterm labor. Sildenafil was used as a vasodilator to reduce the symptoms of PAH. Unfortunately, the pregnancy was terminated at 29 weeks because of PPROM after considering giving lung maturation and neuroprotectant to the fetus. The patient was discharged without complication, but the baby died after eight days of intensive care due to HMD II, which led to respiratory failure.

Conclusion: PAH in pregnancy is a life-threatening condition if untreated. Continuous treatments can help control the symptoms and avoid further complications for both mother and baby.


IPAH, PH, pregnancy, anemia, PPROM

Full Text:



Obican SG, Cleary KL. Pulmonary arterial hypertension in pregnancy. Semin Perinatol. 2014;38(5):289–94.

Afify H, Kong A, Bernal J, Elgendy IY. Pulmonary hypertension in pregnancy: challenges and solutions. Integr Blood Press Control. 2022;15:33–41.

Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016;25(142):431–7.

Quatredeniers M, Mendes‐ferreira P, Santos‐ribeiro D, Nakhleh MK, Ghigna MR, Cohen‐kaminsky S, Perros F. Iron deficiency in pulmonary arterial hypertension: A deep dive into the mechanisms. Cells. 2021;10(2):1–22.

Bazan IS, Mensah KA, Rudkovskaia AA, Adonteng-Boateng PK, Herzog EL, Buckley L, Fares WH. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review. Respir Med. 2018;134(2018):42–6.

Raut MS, Verma A, Maheshwari A, Shivnani G. Think beyond right bundle branch block in atrial septal defect. Ann Card Anaesth. 2017;20(4):475–6.

Terek D, Kayikcioglu M, Kultursay H, Ergenoglu M, Yalaz M, Musayev O, Mogulkoc N, Gunusen I, Akisu M, Kultursay N. Pulmonary arterial hypertension and pregnancy. J Res Med Sci. 2013;18:73–6.

Krishnan S, Fricke EM, Cordoba M, Chalifoux LA, Girgis RE. Pulmonary hypertension complicating pregnancy. Curr Pulmonol Reports. 2021;10(2):71–83.

Anjum H, Surani S. Pulmonary hypertension in pregnancy: A review. Medicina (B Aires). 2021;57:259.

Widyawati W, Jans S, Bor HH, van Dillen J, Lagro-Janssen ALM. The effectiveness of a new model in managing pregnant women with iron deficiency anemia in Indonesia: A nonrandomized controlled intervention study. Birth. 2015;42(4):337–45.

ACOG. ACOG practice bulletin No. 212: Pregnancy and heart disease. Obs Gynecol. 2019;133(5):e320–56.

Friedrisch JR, Friedrisch BK. Prophylactic iron supplementation in pregnancy: A controversial issue. Biochem Insights. 2017;10:1–8.

Sonnweber T, Pizzini A, Tancevski I, Löffler-Ragg J, Weiss G. Anaemia, iron homeostasis and pulmonary hypertension: A review. Intern Emerg Med. 2020;15(4):573–85.

Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, Van Der Laarse WJ, Vonk-Noordegraaf A. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J. 2011;37(6):1386–91.

Pratiwi PI, Emilia O, Kartini F. The effect of anemia on the incidence of premature rupture of membrane (PROM) in Kertha Usada Hospital, Singaraja, Bali. Belitung Nurs J. 2018;4(3):336–42.

Alipour MR, Lookzadeh MH, Namayandeh SM, Pezeshkpour Z, Sarebanhassanabadi M. Comparison of tadalafil and sildenafil in controlling neonatal persistent pulmonary hypertension. Iran J Pediatr. 2017;27(1):10–3.

Henrie AM, Nawarskas JJ, Anderson JR. Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: An evidence-based review. Core Evid. 2015;10:99–108.

Paauw ND, Terstappen F, Ganzevoort W, Joles JA, Gremmels H, Lely AT. Sildenafil during pregnancy: A preclinical meta-analysis on fetal growth and maternal blood pressure. Hypertension. 2017;70(5):998–1006.

Thomas E, Yang J, Xu J, Lima F V., Stergiopoulos K. Pulmonary hypertension and pregnancy outcomes: Insights from the national inpatient sample. J Am Heart Assoc. 2017;6(10):1–12.

Luo J, Shi H, Xu L, Su W, Li J. Pregnancy outcomes in patients with pulmonary arterial hypertension: A retrospective study. Med (United States). 2020;99(23):1–7.

Hall E, Djordjevic M, Mazzullo L. Modified B-Lynch Suture Technique for Prevention of Postpartum Hemorrhage. Obstet Gynecol. 2017;129(5):187S.

Price LC, Martinez G, Brame A, Pickworth T, Samaranayake C, Alexander D et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: A systematic review and expert consensus statement. Br J Anaesth. 2021;126(4):774–90.

Steppan J, Heerdt PM. Pre-operative assessment and peri-operative management of the patient with pulmonary vascular disease. Clin Chest Med. 2021;42(1):133–41.



  • There are currently no refbacks.

Copyright (c) 2022 Stefani Harumsari, Bambang Rahardjo, Valerinna Yogibuana, Mohammad Saifur Rohman

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.